Latest / The Morning Show with Devon Peacock
What is Evusheld and how can it help immunocompromised people avoid symptomatic COVID-19 infections?
On April 14, 2022, Health Canada approved AstraZeneca’s antibody combination, known as Evusheld, to prevent symptomatic COVID-19 infection in immunocompromised people. Infectious disease expert Dr. Isaac Bogoch joins Devon Peacock to discuss.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.